AzTrials
AzTrials

Post-endodontic PainPhase 2NCT06980870

Effect of Pre-medication With Anti-inflammatory Drugs(Ibuprofen and Dexamethasone)on Post-Endodontic Pain

A Phase 2 study testing Anti-inflammatory drug (ibuprofen) and Anti-inflammatory drug (dexamethsaone) in people with Post-endodontic Pain and Ibuprofen, run by Armed Forces Institute of Dentistry, Pakistan at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain with symptomatic irreversible pulpitis Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Post-endodontic Pain, Ibuprofen, Dexamethasone
What is being tested?
Anti-inflammatory drug (ibuprofen) and Anti-inflammatory drug (dexamethsaone)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 sitePakistan
Study dates
15 Feb 2025to 15 Jun 2025
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Permanent teeth with acutely inflamed pulp without swelling or draining sinus.
  • Patients of either gender aged between 18-50 years old.
  • Systemically healthy patients.
  • Patients who agree to attend for recall appointments and provide a written consent.

Who cannot join

  • Patients on preoperative analgesics and antibiotics.
  • Teeth with calcified canals and previously treated teeth.
  • Pregnant and lactating mothers.
  • Patients who are immunocompromised, anxious and mentally handicapped.
  • Patients who are allergic to any of the test medications.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Quratulain Abbasi, BDS contact

00923315317467

quratulain.abbasi@gmail.com

Maha Ali Mirza, BDS contact

00923365605412

mahaalimirza5@gmail.com

Pakistan1 site, 1 recruiting
  • Armed Forces Institute Of Dentistry

    Rawalpindi, 46000

    Quratulain Abbasi, BDS, 00923315317467, quratulain.abbasi@gmail.com

    Maha Ali Mirza, BDS, 009923365605412, mahaalimirza5@gmail.com

    Recruiting

Other trials in Pakistan

About this study

Official title: Effect of Pre-medication With Anti-inflammatory Drugs(Ibuprofen and Dexamethasone)on Post-Endodontic Pain With Symptomatic Irreversible Pulpitis

Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain with symptomatic irreversible pulpitis

Read the detailed description

Study will be conducted after the approval of Institutional Ethics Review Committee, AFID (ANX "A").

A total of 130 entitled patients reporting to Operative Dentistry Department, Armed Forces Institute of Dentistry will be invited for participation in this study. The procedure will be explained to the patients and their parents in Urdu language and a written informed consent will be taken (ANX "B") They will be screened for inclusion by taking history, performing relevant clinical examination and necessary tests along with peri-apical radiographs. Patients fulfilling the inclusion criteria will be divided into two groups using consecutive non random sampling.

Group 1: Patients treated with premedication of Non steroidal anti inflammatory drug (Ibuprofen) Group 2: Patients treated with premedication of Steroidal anti inflammatory drug (Dexamethsone)

Both groups will receive medication 15 mins before intiating root canal treatment. Root canal treatment will then be initiated under local anesthesia and rubber dam isolation. Working length will be taken 1mm from radiographic apex with apex locator and will be confirmed with radiograph. The root canals will be instrumented with ProTaper Next system under copious irrigation with 5.25% sodium hypochlorite (NaOCl). Patency will be confirmed with a #10 K file between each instrument change. The root canals will be flushed with 5 mL of 17% EDTA solution. To control the microbiological impact on post-operative pain calcium hydroxide will be used as an intra-canal medicament and likewise 5.25% sodium hypochlorite as an irrigant in both groups. Following instrumentation and calcium hydroxide placement in the canal using lentulo spirals, the cavity will be temporarily sealed with cavit.

At the end of every appointment, patient will be given a visual analogue scale. The patient will be advised to mark the line corresponding with the intensity of his pain at 24, 48 and 72 hours after the first visit. The patient will be recalled after one week for obturation and final full coverage restoration. Analgesics will be prescribed in case of severe intolerable pain.

Being tested
Anti-inflammatory drug (ibuprofen), Anti-inflammatory drug (dexamethsaone)
Keywords
post-endodontic pain, ibuprofen, dexamethasone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Anti-inflammatory drug (ibuprofen)Drug

    Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain

  • Anti-inflammatory drug (dexamethsaone)Drug

    Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain

Study groups in NCT06980870
Study groupRoleWhat they receive
Pain with ibuprofenActive comparatorEffect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain
Receives: Drug: Anti-inflammatory drug (ibuprofen)
Pain with dexamethasoneActive comparatorEffect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain
Receives: Drug: Anti-inflammatory drug (dexamethsaone)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. effect of pre-medication(ibuprofen and dexamethasone ) on post-endodontic pain

    Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain on visual analogue scale

    Measured: 24 hours

  2. effect of pre-medication(ibuprofen and dexamethasone ) on post-endodontic pain

    Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain on visual analogue scale

    Measured: 48 hours

  3. effect of pre-medication(ibuprofen and dexamethasone ) on post-endodontic pain

    Effect of pre-medication with anti-inflammatory drugs(ibuprofen and dexamethasone)on Post-Endodontic pain on visual analogue scale

    Measured: 72 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2025
  2. Study start15 Feb 2025
  3. Primary completion15 Jun 2025 (estimated)
  4. Study completion15 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
130 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06980870
Sponsor's protocol ID
Ibuprofen versus Dexamethasone
Status last verified
Feb 2025
First submitted
15 Feb 2025
Last updated
20 May 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Anti-inflammatory drug (ibuprofen) and Anti-inflammatory drug (dexamethsaone) in people with Post-endodontic Pain and Ibuprofen, run by Armed Forces Institute of Dentistry, Pakistan at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Quratulain Abbasi, BDS (00923315317467, quratulain.abbasi@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

effect of pre-medication(ibuprofen and dexamethasone ) on post-endodontic pain (time frame: 24 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in